ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 54 filers reported holding ARGOS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 1.4%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pharmstandard International S.A. | 13,242,279 | $64,887,000 | 55.88% |
Pharmstandard International S.A. | 5,120,604 | $27,390,000 | 23.59% |
SANDERS MORRIS HARRIS LLC | 292,512 | $1,433,000 | 0.66% |
WALL STREET ASSOCIATES | 82,850 | $406,000 | 0.27% |
WASATCH ADVISORS LP | 3,254,211 | $15,946,000 | 0.24% |
ALTRINSIC GLOBAL ADVISORS LLC | 172,505 | $845,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,524 | $595,000 | 0.01% |
Alyeska Investment Group, L.P. | 200,000 | $980,000 | 0.01% |
Acrospire Investment Management LLC | 1,800 | $9,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,024,428 | $5,020,000 | 0.00% |